Expansion strategies for human mesenchymal stromal cells culture under xeno-free conditions (2017)
- Authors:
- USP affiliated authors: TRAINA, FABÍOLA - FMRP ; COVAS, DIMAS TADEU - FMRP
- Unidade: FMRP
- DOI: 10.1002/btpr.2494
- Subjects: CULTURA DE CÉLULAS; PROLIFERAÇÃO CELULAR; CÉLULAS CULTIVADAS; GLICOSE; CARIOTIPAGEM; CORDÃO UMBILICAL
- Keywords: Mesenchymal cell
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Biotechnology Progress
- ISSN: 8756-7938
- Volume/Número/Paginação/Ano: v. 33, n. 5, p. 1358-1367, 2017
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
TOZETTI, Patrícia Aparecida et al. Expansion strategies for human mesenchymal stromal cells culture under xeno-free conditions. Biotechnology Progress, v. 33, n. 5, p. 1358-1367, 2017Tradução . . Disponível em: https://doi.org/10.1002/btpr.2494. Acesso em: 11 fev. 2026. -
APA
Tozetti, P. A., Caruso, S. R., Mizukami, A., Fernandes, T. R., Silva, F. B. da, Traina, F., et al. (2017). Expansion strategies for human mesenchymal stromal cells culture under xeno-free conditions. Biotechnology Progress, 33( 5), 1358-1367. doi:10.1002/btpr.2494 -
NLM
Tozetti PA, Caruso SR, Mizukami A, Fernandes TR, Silva FB da, Traina F, Covas DT, Orellana MD, Swiech K. Expansion strategies for human mesenchymal stromal cells culture under xeno-free conditions [Internet]. Biotechnology Progress. 2017 ; 33( 5): 1358-1367.[citado 2026 fev. 11 ] Available from: https://doi.org/10.1002/btpr.2494 -
Vancouver
Tozetti PA, Caruso SR, Mizukami A, Fernandes TR, Silva FB da, Traina F, Covas DT, Orellana MD, Swiech K. Expansion strategies for human mesenchymal stromal cells culture under xeno-free conditions [Internet]. Biotechnology Progress. 2017 ; 33( 5): 1358-1367.[citado 2026 fev. 11 ] Available from: https://doi.org/10.1002/btpr.2494 - Expansion strategies for human mesenchymal stromal cells culture under xeno‐free conditions
- Characterization of human AB serum for mesenchymal stromal cell expansion
- Familial systemic mastocytosis with germline KIT K509I mutation is sensitive to treatment with imatinib, dasatinib and PKC412
- FMNL1 promotes proliferation and migration of leukemia cells
- SF3B1 mutations are infrequently found in non-myelodysplastic bone marrow failure syndromes and mast cell diseases but, if present, are associated with the ring sideroblast phenotype
- IRS1 (insulin receptor substrate 1)
- Serine protease inhibitor kunitz-type 2 is downregulated in myelodysplastic syndromes and modulates cell–cell adhesion
- Padronização da investigação laboratorial de anticorpos dirigidos contra fármacos em doadores de sangue e pacientes com anemia hemolítica imune
- Molecular effects of the phosphatidylinositol-3-kinase inhibitor NVP-BKM120 on T and B-cell acute lymphoblastic leukaemia
- IL32 expression in peripheral blood CD3+ cells from myelodysplastic syndromes patients
Informações sobre o DOI: 10.1002/btpr.2494 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
